There were 2,237 press releases posted in the last 24 hours and 440,050 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
CohBar Announces First Subjects Dosed in its Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image